Evidence map›Paper›PMID 11119598›Full record

ArticleJournal of virology2001

In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail.

P N Fultz, P J Vance, M J Endres, B Tao, J D Dvorin, I C Davis, J D Lifson, D C Montefiori, M Marsh, M H Malim and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

P N FultzDepartment of Microbiology, University of Alabama, Birmingham, Alabama 35294, USA.
P J Vance
M J Endres
B Tao
J D Dvorin
I C Davis
J D Lifson
D C Montefiori
M Marsh
M H Malim
J A Hoxie
Palmetto Hematology Oncology · USUniversity of Pennsylvania · USMRC Laboratory for Molecular Cell Biology · GBScience Applications International Corporation (United States) · USUniversity College London · GBUniversity of Alabama at Birmingham · US

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007170 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BRASS, LAWRENCE F · 1985 to 2022
$54.0M
HIV AND SIV VIF FUNCTIONR01AI046246 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI MALIM, MICHAEL H · 1999 to 2001
$638k
EVOLUTION OF AN ACUTELY LETHAL SIVR01AI032377 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FULTZ, PATRICIA N · 1992 to 1999
–
VIRAL AND CELLULAR DETERMINANTS OF SIV PATHOGENESISR01AI033854 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HOXIE, JAMES A · 1993 to 1999
–
NIAID NIH HHS AI32377NIAID NIH HHS AI46246NIAID NIH HHS P30 AI027767NIAID NIH HHS R01 AI33854NIGMS NIH HHS T32 GM007170
6 · The paper itself

Abstract

Attenuated simian immunodeficiency viruses (SIVs) have been described that produce low levels of plasma virion RNA and exhibit a reduced capacity to cause disease. These viruses are particularly useful in identifying viral determinants of pathogenesis. In the present study, we show that mutation of a highly conserved tyrosine (Tyr)-containing motif (Yxxphi) in the envelope glycoprotein (Env) cytoplasmic tail (amino acids YRPV at positions 721 to 724) can profoundly reduce the in vivo pathogenicity of SIVmac239. This domain constitutes both a potent endocytosis signal that reduces Env expression on infected cells and a sorting signal that directs Env expression to the basolateral surface of polarized cells. Rhesus macaques were inoculated with SIVmac239 control or SIVmac239 containing either a Tyr-721-to-Ile mutation (SIVmac239Y/I) or a deletion of Tyr-721 and the preceding glycine (DeltaGY). To assess the in vivo replication competence, all viruses contained a stop codon in nef that has been shown to revert during in vivo but not in vitro replication. All three control animals developed high viral loads and disease. One of two animals that received SIVmac239Y/I and two of three animals that received SIVmac239DeltaGY remained healthy for up to 140 weeks with low to undetectable plasma viral RNA levels and normal CD4(+) T-cell percentages. These animals exhibited ongoing viral replication as determined by detection of viral sequences and culturing of mutant viruses from peripheral blood mononuclear cells and persistent anti-SIV antibody titers. In one animal that received SIVmac239Y/I, the Ile reverted to a Tyr and was associated with a high plasma RNA level and disease, while one animal that received SIVmac239DeltaGY also developed a high viral load that was associated with novel and possibly compensatory mutations in the TM cytoplasmic domain. In all control and experimental animals, the nef stop codon reverted to an open reading frame within the first 2 months of inoculation, indicating that the mutant viruses had replicated well enough to repair this mutation. These findings indicate that the Yxxphi signal plays an important role in SIV pathogenesis. Moreover, because mutations in this motif may attenuate SIV through mechanisms that are distinct from those caused by mutations in nef, this Tyr-based sorting signal represents a novel target for future models of SIV and human immunodeficiency virus attenuation that could be useful in new vaccine strategies.

Indexed as

Amino Acid MotifsAmino Acid SequenceAnimalsCodonCytoplasmGene Products, envGene Products, nefMacaca mulattaMolecular Sequence DataMutationSimian Immunodeficiency VirusStructure-Activity RelationshipTyrosineVirus ReplicationCodonGene Products, envGene Products, nefTyrosine

Identifiers

PMID11119598
PMCPMC113922
OpenAlexW2158474306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.